AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assay
Authors: Klinge, J Auerswald, G Budde, U Klose, H Kreuz, W Lenk, H Scandella, D
Citation: J. Klinge et al., Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assay, HAEMOPHILIA, 7(1), 2001, pp. 26-32
Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors
Authors: Ettingshausen, CE Halimeh, S Kurnik, K Schobess, R Wermes, C Junker, R Kreuz, W Pollmann, H Nowak-Gottl, U
Citation: Ce. Ettingshausen et al., Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors, THROMB HAEM, 85(2), 2001, pp. 218-220
Thrombolytic therapy of prosthetic valve thrombosis with recombinant tissue plasminogen activator (rt-PA) in infancy and childhood
Authors: Serpi, M Schmidt, KG Kreuz, W Bucsenez, D Springer, W Hagl, S Ulmer, HE
Citation: M. Serpi et al., Thrombolytic therapy of prosthetic valve thrombosis with recombinant tissue plasminogen activator (rt-PA) in infancy and childhood, Z KARDIOL, 90(3), 2001, pp. 191
Low incidence of genotypic and phenotypic resistance in paediatric HIV-infected patients on long-term first-line antiretroviral triple therapy
Authors: Linde, R Funk, MB Schuster, T Wintergerst, U Notheis, G Klingebiel, T Kreuz, W
Citation: R. Linde et al., Low incidence of genotypic and phenotypic resistance in paediatric HIV-infected patients on long-term first-line antiretroviral triple therapy, AIDS, 15(8), 2001, pp. 1077-1079
Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors
Authors: Nowak-Gottl, U Junker, R Kreuz, W von Eckardstein, A Kosch, A Nohe, N Schobess, R Ehrenforth, S
Citation: U. Nowak-gottl et al., Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors, BLOOD, 97(4), 2001, pp. 858-862
Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries
Authors: Ljung, R Aronis-Vournas, S Kurnik-Auberger, K Van den Berg, M Chambost, H Claeyssens, S Van Geet, C Glomstein, A Hann, I Hill, F Kobelt, R Kreuz, W Mancuso, G Muntean, W Petrini, P Rosado, L Scheibel, E Siimes, M Smith, O Tusell, J
Citation: R. Ljung et al., Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries, HAEMOPHILIA, 6(6), 2000, pp. 619-624
Nelfinavir pharmacokinetics in HIV-infected children: a comparison of twice daily and three times daily dosing
Authors: Schuster, T Linde, R Wintergerst, U Funk, MB Kurowski, M Kreuz, W Hofmann, D
Citation: T. Schuster et al., Nelfinavir pharmacokinetics in HIV-infected children: a comparison of twice daily and three times daily dosing, AIDS, 14(10), 2000, pp. 1466-1468
Molecular biology and clinical manifestation of hereditary factor VII deficiency
Authors: Herrmann, FH Wulff, K Auberger, K Aumann, V Bergmann, F Bergmann, K Bratanoff, E Franke, D Grundeis, M Kreuz, W Lenk, H Losonczy, H Maak, B Marx, G Mauz-Korholz, C Pollmann, H Serban, M Sutor, A Syrbe, G Vogel, G Weinstock, N Wenzel, E Wolf, K
Citation: Fh. Herrmann et al., Molecular biology and clinical manifestation of hereditary factor VII deficiency, SEM THROMB, 26(4), 2000, pp. 393-400
Is recombinant tissue plasminogen activator an option in the treatment of meningococcus-induced purpura?
Authors: Veldman, A Ehrenberg, A Jager, G Ettingshausen, CE Schneider, W Kreuz, W
Citation: A. Veldman et al., Is recombinant tissue plasminogen activator an option in the treatment of meningococcus-induced purpura?, CRIT CARE M, 28(2), 2000, pp. 598-599
Successful extubation with use of C1 esterase inhibitor concentrate in a patient with hereditary angioedema - In reply
Authors: Bork, K Siedlecki, K Bosch, S Schopf, RE Kreuz, W
Citation: K. Bork et al., Successful extubation with use of C1 esterase inhibitor concentrate in a patient with hereditary angioedema - In reply, MAYO CLIN P, 75(8), 2000, pp. 870-870
Asphyxiation by laryngeal edema in patients with hereditary angioedema
Authors: Bork, K Siedlecki, K Bosch, S Schopf, RE Kreuz, W
Citation: K. Bork et al., Asphyxiation by laryngeal edema in patients with hereditary angioedema, MAYO CLIN P, 75(4), 2000, pp. 349-354
Abdominal venous thrombosis in neonates and infants: role of prothromboticrisk factors - a multicentre case-control study
Authors: Heller, C Schobess, R Kurnik, K Junker, R Gunther, G Kreuz, W Nowak-Gottl, U
Citation: C. Heller et al., Abdominal venous thrombosis in neonates and infants: role of prothromboticrisk factors - a multicentre case-control study, BR J HAEM, 111(2), 2000, pp. 534-539
Resistance to activated protein C in patients with deep vein thrombosis and or pulmonary embolism: molecular genetic study of prevalence among patients from various regions in Germany
Authors: Ehrenforth, S Klinke, S Prondzinski, MVD Kreuz, W Ganser, A Scharrer, I
Citation: S. Ehrenforth et al., Resistance to activated protein C in patients with deep vein thrombosis and or pulmonary embolism: molecular genetic study of prevalence among patients from various regions in Germany, DEUT MED WO, 124(25-26), 1999, pp. 783-787
German recommendations for immune tolerance therapy in type A haemophiliacs with antibodies
Authors: Brackmann, HH Lenk, H Scharrer, I Auerswald, G Kreuz, W
Citation: Hh. Brackmann et al., German recommendations for immune tolerance therapy in type A haemophiliacs with antibodies, HAEMOPHILIA, 5(3), 1999, pp. 203-206
Ophthalmic manifestation of congenital protein C deficiency
Authors: Hattenbach, LO Beeg, T Kreuz, W Zubcov, A
Citation: Lo. Hattenbach et al., Ophthalmic manifestation of congenital protein C deficiency, J AAPOS, 3(3), 1999, pp. 188-190
Multicentre evaluation of combined prothrombotic: defects associated with thrombophilia in childhood
Authors: Ehrenforth, S Junker, R Koch, HG Kreuz, W Munchow, N Scharrer, I Nowak-Gottl, U
Citation: S. Ehrenforth et al., Multicentre evaluation of combined prothrombotic: defects associated with thrombophilia in childhood, EUR J PED, 158, 1999, pp. S97-S104
Prothrombotic risk factors in childhood stroke and venous thrombosis
Authors: Heller, C Becker, S Scharrer, I Kreuz, W
Citation: C. Heller et al., Prothrombotic risk factors in childhood stroke and venous thrombosis, EUR J PED, 158, 1999, pp. S117-S121
Prevalence and outcome of intracranial haemorrhage in haemophiliacs - a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH)
Authors: Klinge, J Auberger, K Auerswald, G Brackmann, HH Mauz-Korholz, C Kreuz, W
Citation: J. Klinge et al., Prevalence and outcome of intracranial haemorrhage in haemophiliacs - a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH), EUR J PED, 158, 1999, pp. S162-S165
Portal vein thrombosis in a patient with severe haemophilia A and FV G1691A mutation during continuous infusion of FVIII after intramural jejunal bleeding - Successful thrombolysis under heparin therapy
Authors: Ettingshausen, CE Saguer, IM Kreuz, W
Citation: Ce. Ettingshausen et al., Portal vein thrombosis in a patient with severe haemophilia A and FV G1691A mutation during continuous infusion of FVIII after intramural jejunal bleeding - Successful thrombolysis under heparin therapy, EUR J PED, 158, 1999, pp. S180-S182
Post-trauma coagulation and fibrinolysis in children suffering from severecerebro-cranial trauma
Authors: Becker, S Schneider, W Kreuz, W Jacobi, G Scharrer, I Nowak-Gottl, U
Citation: S. Becker et al., Post-trauma coagulation and fibrinolysis in children suffering from severecerebro-cranial trauma, EUR J PED, 158, 1999, pp. S197-S202
Therapy-resistant haemarthros in a patient with factor VIII inhibitor: successful treatment with recombinant factor VIIa
Authors: Lenz, E Repas-Humpe, M Oldenburg, J Kreuz, W Schroter, W Eber, SW
Citation: E. Lenz et al., Therapy-resistant haemarthros in a patient with factor VIII inhibitor: successful treatment with recombinant factor VIIa, EUR J PED, 158(11), 1999, pp. 951-952
Genotypic and phenotypic resistance under zidovudine and lamivudine therapy in human immunodeficiency virus-infected children
Authors: Funk, M Linde, R Braner, HJ Groeschel, B Kornhuber, B Kreuz, W
Citation: M. Funk et al., Genotypic and phenotypic resistance under zidovudine and lamivudine therapy in human immunodeficiency virus-infected children, EUR J PED, 158(1), 1999, pp. 86-87
Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children
Authors: Funk, MB Linde, R Wintergerst, U Notheis, G Hoffmann, F Schuster, T Kornhuber, B Ahrens, P Kreuz, W
Citation: Mb. Funk et al., Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children, AIDS, 13(13), 1999, pp. 1653-1658
Neonatal sepsis: A challenge in hemostaseology
Authors: Kreuz, W Veldmann, A Fischer, D Schlosser, R Volk, WR Ettingshausen, CE
Citation: W. Kreuz et al., Neonatal sepsis: A challenge in hemostaseology, SEM THROMB, 25(6), 1999, pp. 531-535
Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans
Authors: Ettingshausen, CE Veldmann, A Beeg, T Schneider, W Jager, G Kreuz, W
Citation: Ce. Ettingshausen et al., Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans, SEM THROMB, 25(6), 1999, pp. 537-541
Risultati: 1-25 | 26-30